Caveolin-1 also promotes breast cancer progression by increasing the S100A4 expression in tumor stromal cells through manipulation of stromal cell-derived factor-1 (SDF-1), EGF and tumor protein p53-induced glycolysis, and apoptosis regulator (TIGAR) levels in breast cancer cells [68]. Here, EGF is linked to breast cancer.